Used in peptide synthesis to introduce a protected, N-methylated glutamic acid residue. The FMOC group allows for mild deprotection under basic conditions, making it compatible with solid-phase synthesis. N-methylation can enhance peptide stability and modulate biological activity, such as improving metabolic resistance or altering conformation. Commonly applied in the development of therapeutic peptides and research compounds where backbone modifications are needed.